Angiotensin-converting enzyme inhibitors (ACEIs) and age-related maculopathy (ARM): cross-sectional findings from the Blue Mountains Eye Study.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Acta ophthalmologica

• Publication date

  2004-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1600-0420.2004.00265.XPMID 15115451
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The epidemiology of age-related macular degeneration.

  2004cited by this paper
• Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy

  2004cited by this paper
• The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam eye study.

  2003cited by this paper
• Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study.

  2003cited by this paper
• The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study.

  2003cited by this paper
• Blood pressure, atherosclerosis, and the incidence of age-related maculopathy : The Rotterdam Study

  2003cited by this paper
• Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio.

  2003cited by this paper
• Microvascular angiogenesis and the renin-angiotensin system

  2002cited by this paper
• Fundamentals of endothelial function for the clinical cardiologist.

  2002cited by this paper
• Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study.

  2002cited by this paper
• Inflammation and Atherosclerosis

  2002cited by this paper
• Complement activation and inflammatory processes in Drusen formation and age related macular degeneration.

  2001cited by this paper
• Medication use and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study.

  2001influential reference
• Risk factors for age-related macular degeneration.

  2001cited by this paper
• Immunological and aetiological aspects of macular degeneration.

  2001cited by this paper
• Body mass index and the incidence of visually significant age-related maculopathy in men.

  2001cited by this paper
• Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction.

  2001cited by this paper
• Risk factors for age-related maculopathy: the Visual Impairment Project.

  2001influential reference
• Risk factors for age-related macular degeneration: Pooled findings from three continents.

  2001cited by this paper
• Captopril improves retinal neovascularization via endothelin-1.

  2001cited by this paper
• Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.

  2001cited by this paper
• Retinal Neovascularization Is Prevented by Blockade of the Renin-Angiotensin System

  2000cited by this paper
• Dietary fat and fish intake and age-related maculopathy.

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease

  2000cited by this paper
• The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration.

  2000cited by this paper
• Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group.

  2000cited by this paper
• Do age-related macular degeneration and cardiovascular disease share common antecedents?

  1999cited by this paper
• Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study.

  1998cited by this paper
• Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.

  1998cited by this paper
• Atherosclerosis is an Inflammatory Disease

  1998cited by this paper
• Angiotensin Converting Enzyme Inhibition, with Quinapril, Improves Endothelial Vasomotor Dysfunction in Patients with Coronary Artery Disease: the TREND Study (Trial on REversing ENdothelial Dysfunction)

  1996cited by this paper
• Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.

  1996cited by this paper
• Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system.

  1996cited by this paper
• Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study.

  1995cited by this paper
• An international classification and grading system for age-related maculopathy and age-related macular degeneration

  1995cited by this paper
• Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.

  1995cited by this paper
• An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group.

  1995cited by this paper
• Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.

  1994cited by this paper
• Angiotensin levels in the eye.

  1994cited by this paper
• The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study.

  1993cited by this paper
• Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.

  1993cited by this paper
• Stimulation of Plasminogen Activator Inhibitor In Vivo by Infusion of Angiotensin II Evidence of a Potential Interaction Between the Renin‐Angiotensin System and Fibrinolytic Function

  1993cited by this paper
• The Wisconsin age-related maculopathy grading system.

  1991cited by this paper
• Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.

  1977cited by this paper

• Angiotensin‐converting enzyme inhibitors and risk of age‐related macular degeneration in individuals with hypertension

  2022cites this paper
• Renin-Angiotensin System Inhibitor Usage and Age-Related Macular Degeneration among Hypertensive Patients: Results from the National Health and Nutrition Examination Survey, 2005–2008

  2020cites this paper
• Publications for Jie Jin Wang 2016

  2016cites this paper
• Epidemiology of Age-Related Macular Degeneration among the Elderly Population in Thailand.

  2015cites this paper
• Essential hypertension in the pathogenesis of age-related macular degeneration: a review of the current evidence.

  2015cites this paper
• The Relationship Between Angiotensin Converting Enzyme Insertion/deletion Polymorphism and Age-related Macular Degeneration

  2011cites this paper
• Epidemiology of Age-Related Macular Degeneration Early in the 21st Century

  2007cites this paper
• Genetic and modifiable risk factors for age-related macular degeneration

  2006cites this paper